SMALL MOLECULES TARGETING ROR1 INDUCE SPECIFIC KILLING OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS

被引：0
|
作者：
Moshfegh, A. [1 ]
Khan, S. [1 ]
Vagberg, J. [2 ]
Bystrom, S. [2 ]
Hojat-Farsangi, M. [1 ]
Mansouri, L. [1 ]
Sandin, A. [1 ]
Manesh, A. Danesh [1 ]
Osterborg, A. [3 ]
Mellstedt, H. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Kancera AB, Stockholm, Sweden
[3] Karolinska Univ Hosp, Stockholm, Sweden
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1061
引用
收藏
页码：433 / 433
页数：1
相关论文
共 50 条
  • [1] Effect of ROR1-targeting small molecules on chronic lymphocytic leukemia (CLL) cells
    Mellstedt, Hakan
    Khan, Salam
    Vagberg, Jan
    Bystrom, Styrbjorn
    Schultz, Johan
    Farsangi, Mohammad Hojat
    Mansouri, Ladan
    Manesh, Amir Hossein Danesh
    Osterborg, Anders
    Moshfegh, Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells
    A H Daneshmanesh
    M Hojjat-Farsangi
    A S Khan
    M Jeddi-Tehrani
    M M Akhondi
    A A Bayat
    R Ghods
    A-R Mahmoudi
    R Hadavi
    A Österborg
    F Shokri
    H Rabbani
    H Mellstedt
    Leukemia, 2012, 26 : 1348 - 1355
  • [3] Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells
    Daneshmanesh, A. H.
    Hojjat-Farsangi, M.
    Khan, A. S.
    Jeddi-Tehrani, M.
    Akhondi, M. M.
    Bayat, A. A.
    Ghods, R.
    Mahmoudi, A-R
    Hadavi, R.
    Osterborg, A.
    Shokri, F.
    Rabbani, H.
    Mellstedt, H.
    LEUKEMIA, 2012, 26 (06) : 1348 - 1355
  • [4] The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
    Hojjat-Farsangi, Mohammad
    Khan, Abdul Salam
    Daneshmanesh, Amir Hossein
    Moshfegh, Ali
    Sandin, Asa
    Mansouri, Ladan
    Palma, Marzia
    Lundin, Jeanette
    Osterborg, Anders
    Mellstedt, Hakan
    PLOS ONE, 2013, 8 (10):
  • [5] Targeting of Chronic Lymphocytic Leukemia B Cells with a Novel Monoclonal Antibody to ROR1
    Cui, Bing
    Widhopf, George F., II
    Yu, Jian
    Martinez, Daniel
    Avery, Esther
    Zhang, Suping
    Chen, Liguang
    Wu, Rongrong
    Wu, Christina C. N.
    Prussak, Charles
    Kipps, Thomas J.
    BLOOD, 2011, 118 (21) : 450 - 450
  • [6] Efficient Gene Delivery to Chronic Lymphocytic Leukemia (CLL) Cells with Microbubbles Bearing ROR1 Antibody
    Zhang, Suping
    Cui, Wenjin
    Mattrey, Robert
    Kipps, Thomas J.
    BLOOD, 2011, 118 (21) : 1232 - 1232
  • [7] Does CD5 have an effect on the expression of ROR1 in chronic lymphocytic leukemia (CLL)?
    Alsulami, H.
    Hallek, M.
    Kreuzer, K. A.
    ONKOLOGIE, 2011, 34 : 138 - 139
  • [8] Targeting Human B Cell Chronic Lymphocytic Leukemia With a Monoclonal Antibody Specific for the Receptor Tyrosine Kinase ROR1
    Baskar, Sivasubramanian
    Yang, Jiahui
    Rader, Christoph
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 969 - 969
  • [9] ROR1 Isoforms Are Constitutively Phosphorylated in Chronic Lympho cytic Leukemia (CLL) - a Survival Factor for CLL Cells
    Mellstedt, Hakan
    Hojjat-Farsangi, Mohammad
    Mansouri, Ladan
    Osterborg, Anders
    Rabbani, Hodjattallah
    BLOOD, 2011, 118 (21) : 775 - 776
  • [10] ROR1 Expression Is Associated with Oncogenic Dedifferentiation in Chronic Lymphocytic Leukemia
    Ghia, Emanuela M.
    Choi, Michael Y.
    Widhopf, George F., II
    Rassenti, Laura Z.
    Kipps, Thomas J.
    BLOOD, 2018, 132
12345